Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Richard Hughes,
  2. Jeremy Rees,
  3. Nigel Smeeton,
  4. John Winer
  1. Professor of neurology MRC clinical research fellow Department of Neurology, United Medical and Dental Schools, Guy's Hospital, London SE1 9RT
  2. Lecturer in medical statistics Department of Public Health Medicine, Guy's Hospital
  3. Consultant neurologist Queen Elizabeth Hospital, Birmingham B29 6JD

    EDITOR,—Three cases of Guillain-Barre syndrome were reported to the Committee on Safety of Medicines in Britain during a recent programme which immunised just under 8 million children with measles/rubella vaccine (DM Salisbury, Department of Health, personal communication). This low figure might be due to underreporting but is reassuringly less than the background risk of developing the syndrome (which would have been expected to be about 7.6 cases in the month after immunisation in the United Kingdom, based on the typical …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    Read related article

    See previous polls

    BMJ most popular